Genentech

SUSVIMO - Cost

Last Updated: April 1st, 2024

HCPCS:

J2779

HCPCS Code Descriptor:

Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg

Medicare Payment Limit:

The SUSVIMO Medicare Payment Limit is $80.374

Average Sale Price:

SUSVIMO ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The SUSVIMO Medicare Co-insurance percentage is 20%. SUSVIMO's Medicare Co-insurance amount is $16.07 per HCPCS unit.

APC Code:

The Susvimo APC Code is: 9439

APC Payment Limit:

The APC Payment Limit for SUSVIMO is available. Login to view.

Susvimo Cost Information:

SUSVIMO, manufactured by Genentech, became effective on July 1, 2022 and is aligned to HCPCS J2779. SUSVIMO has two NDCs mapped to J Code: J2779 with possible errors or discrepancies found with both of these alignments. Pricing has had little to no movement from its inception.

ACCESS PRICING AND MORE BY REGISTERING

Susvimo’s wholesale acquisition cost (WAC) information was last updated on:
October 22, 2021
Susvimo’s average wholesale price (AWP) information was last updated on:
October 22, 2021